Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy C Okell

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Malaria Journal|December 10, 2020
Asymptomatic recrudescence after artemether-lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysisRida Mumtaz, Lucy C Okell, Joseph D Challenger
Scientific Reports|August 9, 2017
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in AfricaLucy C Okell, Jamie T Griffin, Cally Roper
Trends in Parasitology|October 12, 2016
Mathematical Modelling to Guide Drug Development for Malaria EliminationHannah C Slater, Lucy C Okell, Azra C Ghani
The Journal of Infectious Diseases|October 24, 2009
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysisLucy C Okell, Azra C Ghani, Emily Lyons, et al.
Nature Communications|November 11, 2017
Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modellingJoseph D Challenger, Katia Bruxvoort, Azra C Ghani, et al.
Malaria Journal|September 15, 2012
From intervention to impact: modelling the potential mortality impact achievable by different long-lasting, insecticide-treated net delivery strategiesLucy C Okell, Lucy Smith Paintain, Jayne Webster, et al.
Malaria Journal|January 8, 2016
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan AfricaHannah C Slater, Jamie T Griffin, Azra C Ghani, et al.
Malaria Journal|August 18, 2017
Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatmentMichael T Bretscher, Jamie T Griffin, Azra C Ghani, et al.
Malaria Journal|July 11, 2008
Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trialsLucy C Okell, Chris J Drakeley, Azra C Ghani, et al.
Aging & Mental Health|October 16, 2008
Early motherhood and mental health in midlife: a study of British and American cohortsJohn C Henretta, Emily M D Grundy, Lucy C Okell, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Malaria Journal|December 10, 2020
Asymptomatic recrudescence after artemether-lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysisRida Mumtaz, Lucy C Okell, Joseph D Challenger
Scientific Reports|August 9, 2017
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in AfricaLucy C Okell, Jamie T Griffin, Cally Roper
Trends in Parasitology|October 12, 2016
Mathematical Modelling to Guide Drug Development for Malaria EliminationHannah C Slater, Lucy C Okell, Azra C Ghani
The Journal of Infectious Diseases|October 24, 2009
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysisLucy C Okell, Azra C Ghani, Emily Lyons, et al.
Nature Communications|November 11, 2017
Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modellingJoseph D Challenger, Katia Bruxvoort, Azra C Ghani, et al.
Malaria Journal|September 15, 2012
From intervention to impact: modelling the potential mortality impact achievable by different long-lasting, insecticide-treated net delivery strategiesLucy C Okell, Lucy Smith Paintain, Jayne Webster, et al.
Malaria Journal|January 8, 2016
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan AfricaHannah C Slater, Jamie T Griffin, Azra C Ghani, et al.
Malaria Journal|August 18, 2017
Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatmentMichael T Bretscher, Jamie T Griffin, Azra C Ghani, et al.
Malaria Journal|July 11, 2008
Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trialsLucy C Okell, Chris J Drakeley, Azra C Ghani, et al.
Aging & Mental Health|October 16, 2008
Early motherhood and mental health in midlife: a study of British and American cohortsJohn C Henretta, Emily M D Grundy, Lucy C Okell, et al.
Pageof 6